Screening for phaeochromocytoma in patients with acute cerebrovascular disease: Is it necessary?
Mohamed Zainuddin N, Sthaneshwar P, Ratnasingam J.
Malays J Pathol. 2020 Aug;42(2):203-207.
Heart and catecholamines.
Prichard BN, Owens CW, Smith CC, Walden RJ.
Acta Cardiol. 1991;46(3):309-22.
Pheochromocytoma triggered by coronavirus disease 2019: a case report.
Naghshineh H, Hasanpour A, Ziaei N, Sadeghi M, Meftah N.
J Med Case Rep. 2022 Jun 10;16(1):233. doi: 10.1186/s13256-022-03378-8.
TRANYLCYPROMINE CEPHALGIA.
MANN AM, LAING WA.
Can Med Assoc J. 1963 Nov 30;89(22):1115-8.
Hypertensive emergencies.
Koch-Weser J.
N Engl J Med. 1974 Jan 24;290(4):211-4. doi: 10.1056/NEJM197401242900407.
Life-threatening events in patients with pheochromocytoma.
Riester A, Weismann D, Quinkler M, Lichtenauer UD, Sommerey S, Halbritter R, Penning R, Spitzweg C, Schopohl J, Beuschlein F, Reincke M.
Eur J Endocrinol. 2015 Dec;173(6):757-64. doi: 10.1530/EJE-15-0483. Epub 2015 Sep 7.
Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas.
Y-Hassan S, Falhammar H.
J Clin Med. 2020 Jul 30;9(8):2435. doi: 10.3390/jcm9082435.
Reversible Cerebral Vasoconstriction Syndrome Associated with a Suprarenal Mass.
Pantoja-Ruiz C, Ricaurte-Fajardo A, Ocampo-Navia MI, Coral-Casas J.
Prague Med Rep. 2020;121(2):107-113. doi: 10.14712/23362936.2020.9.
Progress in treatment and follow-up of pheochromocytoma.
Zhou Y, Tai Y, Shang J.
Eur J Surg Oncol. 2025 Aug;51(8):110144. doi: 10.1016/j.ejso.2025.110144. Epub 2025 May 10.
Causes of death in patients with malignant adrenal tumours: a population-based analysis.
Zheng Y, Ren S, Yan Z, Hu T, Feng Y, Wang D, Fan S, Ren S.
J Endocrinol Invest. 2025 Jun;48(6):1415-1431. doi: 10.1007/s40618-025-02555-y. Epub 2025 Feb 24.
